Becaris Publishing

A disease progression model comparing the long-term mobility and respiratory outcomes of adults with late-onset Pompe disease receiving cipaglucosidase alfa plus miglustat versus alglucosidase alfa
- Amy Dymond,
- Will Green,
- Matthew Crabtree,
- Alasdair MacCulloch,
- Neil Johnson,
- Simon Shohet,
- Vera Gielen,
- Sophie Clarke,
- Patrick Deegan, and
- Jordi Diaz-Manera
Journal of Comparative Effectiveness Research
15 Jul 2026
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 27
- Paul Arora and
- Sreeram V Ramagopalan
Journal of Comparative Effectiveness Research
14 Jul 2026

Market access and HTA developments with Sreeram Ramagopalan: The HEMA benefits debate and delays in health plan coverage updates

The Evidence Base

15 Jul 2026
Following the patient journey: How connected data and evolving methods are reshaping real-world evidence

The Evidence Base

15 Jul 2026

Journal of Comparative Effectiveness Research
Open access, peer-reviewed journal offering rapid publication for all aspects of HEOR and related areas

Real World Evidence

Health Technology Assessment

Health Technology Assessment

The Evidence Base
Online hub providing the latest news, opinion and insights into HEOR, RWE, HTA and more